Shares of revenue are estimates for Q2 2026, not figures from a filing.
Medicaid managed-care plans
Health coverage for eligible low-income people, children, people with disabilities and others; Centene arranges care through contracted doctors, hospitals and other providers.
Medicare Advantage plans
Private health plans that provide Medicare benefits, including plans that coordinate care for people enrolled in both Medicare and Medicaid.
Medicare Prescription Drug Plans
Standalone plans that provide prescription drug coverage to people eligible for Medicare.
Ambetter Health insurance
Individual and family health insurance sold through the federal and state Health Insurance Marketplaces.
Ambetter Health Solutions plans
Individual health insurance plans compatible with employer arrangements that reimburse workers for insurance premiums and eligible medical costs.
AcariaHealth specialty pharmacy services
Pharmacy services and clinical support for people with complex or long-term health conditions, including help accessing prescribed medicines.
Centene arranges health care for people enrolled in Medicaid, Medicare and private health plans. Its largest business is Medicaid coverage, which it provides under contracts with state governments; it also sells Medicare Advantage plans, prescription drug plans and individual health insurance. It served 25.9 million members across its health plans and drug plans (June 30, 2026, high).
Built from Centene Corp.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$70.46+0.4%Nov 11 close
Figures through September 30, 2026, from the 10-Q filed October 27, 2026
Centene sells Medicaid health coverage to state governments for low-income people, plus Medicare coverage to older adults and people with disabilities.
Just reported
From Centene's results release of October 27, 2026; its quarterly report has since been filed.
Actual
$50.65B
+1.9% y/y
-5.5% q/q
Guided
—
No guide given
Actual
-$0.14
Guided
—
No guide given
Actual
-$307M
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Centene is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Grade D
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 41 quarters of Centene Corp.’s grade history. The other 39 go back to October 2016.